Dr. David Woolf is a Consultant Clinical Oncologist specializing in radiotherapy for breast and lung cancer and oligometastasis. He has extensive experience in Stereotactic Ablative Radiotherapy (SABR/SBRT) and is the lead for this technique. Dr. Woolf trained in London and holds a Master's Degree in Oncology from the Institute of Cancer Research and a Doctorate of Medicine from Mount Vernon Cancer Centre. He is involved in leading international research, including a multi-million pound NIHR grant to study lung radiotherapy, and has authored over 40 research publications. His expertise includes radiotherapy, chemotherapy, hormone therapy, biological therapy, immunotherapy, stereotactic body radiotherapy (SABR), and proton beam therapy.